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2113-Plat
DNA Based Dual-Spring Cross Shaped Nanoactuator
Alexander H. Mo, Preston B. Landon, Ratnesh Lal.
University of California, San Diego, La Jolla, CA, USA.
DNA is an attractive platform for nanotechnology applications because of its
size, specificity, and designability. However constructing DNA-based plat-
forms that can do work is difficult. We have developed a DNA-based cross-
shaped nanoactuator system that cycles between an extended and contracted
confirmation relying on strand displacement reactions. The actuator contains
4 structural strands with two unique DNA ‘‘zipper’’ sequences. Each zipper
sequence employs traditional adenosine-thymine nucleotides as well as non-
traditional inosine-cytidine nucleotides. The I-C bond consists of only 2 hydro-
gen bonds as opposed to the typical 3 hydrogen bonds found in G-C bonds. The
actuator is extended by inserting two ssDNA which are the natural comple-
ments to the zipper sequences. The natural complements have a stronger bind-
ing affinity to one side of the zipper than both zipper strands have to each other,
thus unraveling and allowing the actuator to extend. The two contraction
strands contain sequences which are a natural complement to parts of the open-
ing strand. When they bind to the extension sequences, the zippers are able to
rebind and this contracts the actuator. Proper assembly and function of the de-
vices was confirmed
using fluorescent
DNA gel electropho-
resis, AFM imaging,
and time-lapsed fluo-
rescence.2114-Plat
Creation of a Biological Wire using Cell-Targeted Paramagnetic Beads
Eugenio Cingolani1, Vittoria Ionta1, Alessandro Giacomello2,
Eduardo Marba´n1, Hee Cheol Cho1.
1Cedars Sinai Heart Institute, Los Angeles, CA, USA, 2Univeristy of
La Sapienza, Rome, Italy.
Introduction: Cardiac conduction delays and blocks are associated with re-
entrant arrhythmias. We sought to create a novel approach to treat such disor-
ders by engineering biological wires designed to bridge or bypass zones of slow
conduction.
Methods: Paramagnetic beads (8 mm diameter) were conjugated with an anti-
body specific for g-sarcoglycan, a cardiomyocyte cell-surface antigen.
Freshly-isolated neonatal rat ventricular cardiomyocytes (NRVMs) were ex-
posed to antibody-coated beads. A biological wire (BioWire) was formed by
exposing the bead-NRVM complex to a linear magnetic field. To create a model
of conduction block, NRVMs were plated in monolayers and mechanically in-
terrupted along the middle. Action potential (AP) propagation and AP duration
were measured by optical mapping.
Results: Prior to bridging, the two sides of an interrupted NRVM monolayer
beat independently. In order to re-establish conduction, BioWire was formed
perpendicular to the axis of interruption, by placing a magnet bridging the
two halves underneath the monolayer. Within one day of BioWire implanta-
tion, the two NRVM islands beat synchronously, and APs propagated from
one island to the other via BioWire with a conduction velocity (CV) of
1854 cm/s. Action potential morphology and APD90 were similar in BioWire
(APD90=44355ms) and the adjacent monolayers (APD90=439512ms,
p=ns). BioWire was amenable to further engineering. Cardiosphere-derived
cells (CDCs), which can couple to and exert anti-apoptotic effects on cardio-
myocytes, were mixed with NRVMs and conjugated to the beads via CD105
(%5% CDCs, BioWire-mx) in order to enhance the physical integrity of Bio-
Wire. When paced, BioWire-mx showed faster CV than that of BioWire (1756
vs 1151 cm/s, n=4).
Conclusion: This proof-of-concept study demonstrates that BioWire could re-
establish cardiac conduction between isolated regions of two-dimensional car-
diac tissue. The approach is highly generalizable, offering a novel platform to
engineer biologically-compatible materials for relaying electrical signals.
2115-Plat
Molecularly Defined Re-Wiring of Electron Transport in Living Cells
Heather M. Jensen1, Jay T. Groves2, Caroline M. Ajo-Franklin3.
1UC Berkeley/Lawrence Berkeley National Lab, Berkeley, CA, USA,
2UC Berkeley, Berkeley, CA, USA, 3Lawrence Berkeley National Lab,
Berkeley, CA, USA.Cellular-electrical connections have the potential to combine the specialties of
the technological world with those of the living world. However, cell mem-
branes are natural insulators, inherently creating a barrier between intracellular
electrons and inorganic materials. To overcome this barrier, we have ‘grown’
electrical connections in living cells by engineering the cell to construct
a well-defined electron conduit. The dissimilatory metal-reducing microbe,
Shewanella oneidensis MR-1, inspired our approach: it has the unusual ability
to transport electrons to extracellular minerals via a trans-membrane electron
transport pathway (ETP). We seek to generalize this ability to grow electrical
contacts between microbes and inorganic materials, and thus have genetically
re-engineered a portion of the Shewanella ETP into Escherichia coli (Fig. A).
Native E. coli proteins complete the partial ETP by acting as a direct electron
donor to the functionally expressed Shewanella proteins. These ’electrified’
strains exhibit ~8x and ~4x faster metal reducing efficiency with soluble metals
and insoluble metal oxides, respectively, than wild-type E. coli (Fig. B). These
experiments provide the first steps towards engineering of hybrid living-
non-living systems.
Our next objective
is to measure direct
electrical output
from the ‘electrified’
strains to an elec-
trode (Fig. C).2116-Plat
Sensitive and Selective Nucleic Acid Capture with Shielded Covalent
Probes
Jeffrey R. Vieregg, Hosea Nelson, Brian Stoltz, Niles A. Pierce.
California Institute of Technology, Pasadena, CA, USA.
Understanding how the parts encoded in the genome interact to build and sus-
tain life is one of the key challenges of modern biology, and nucleic acid probes
are at the heart of many of the techniques used to probe these interactions. In
vitro, they are used to identify genotypes and species, detect nucleic acid-
protein interactions, and measure gene expression patterns in time and space.
In vivo, synthetic nucleic acids are used to inhibit expression for research
and therapeutic interventions. In each of these applications, however, the power
of nucleic acid probes is limited by imperfect selectivity (binding of undesired
targets) and incomplete affinity (not all desired targets are bound). These lim-
itations stem from reliance on base pairing to both bind the desired target and
discriminate against off-target sequences. Longer probes bind the designed tar-
get securely but can also pair imperfectly with undesired targets. Shorter probes
or structured probes such as molecular beacons discriminate mismatches effec-
tively, but at the cost of reduced affinity for the desired target.
We have recently developed a new technology, shielded covalent probes, in or-
der to resolve the selectivity/affinity tradeoff. The probes are designed to fold
into hairpins in the absence of target, ensuring selectivity through competition
between probe-probe and probe-target pairing. Once hybridization is complete,
photo-activatable crosslinkers form covalent bonds between the probe and tar-
get that are far stronger than the non-covalent interactions of base pairing. In
vitro assays show that designed targets are covalently bound with nearly quan-
titative yield, and mismatches are efficiently rejected. Furthermore, the bonds
are stable under extremely stringent conditions, enabling removal of uncros-
slinked molecules. The crosslinks can then be reversed to release the isolated
target. We envision a wide array of applications for these probes.
2117-Plat
Discovery of VEGF-KDR Binding Inhibitors by Screening Small-Molecule
Microarrays with Label-Free Ellipsometric Scanners
James P. Landry1, Yiyan Fei1, Xiangdong Zhu1, Yaohuang Ke2,
Y. Peter Li2, Guoliang Yu2.
1University of California at Davis, Davis, CA, USA, 2Epitomics Inc,
Burlingame, CA, USA.
Developing new small-molecule drugs against protein targets requires screen-
ing large collections of structurally diverse compounds for those with suffi-
ciently high affinity to and inhibition effect on a protein target before further
structural optimization and developmental work. Small-molecule microarrays
(SMM) with a suitable binding assay platform are one of the viable high-
throughput screening options. We demonstrate that by combining an oblique-
incidence reflectivity difference optical scanner with microarrays, we can
screen >10,000 compounds per glass slide for ligands to a protein target with-
out fluorescence labeling. Using such a platform, we recently screened 8,000
small molecule compounds from the National Cancer Institute Developmental
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4,000 compounds in duplicate, on isocyanate-functionalized glass slide) against
vascular endothelial growth factor (VEGF). We identified 170 ligands that
bound VEGF with affinities in the range of 0.2 nM to 10 nM. By measuring
binding curves of ligand-VEGF mixtures to surface-immobilized KDR with
our scanners, we identified 12 compounds among the 170 ligands that actually
inhibited VEGF-KDR reactions at compound concentrations below 100 mM.
We further determined the IC50 values (albeit in vitro and microarray-based)
for these 12 compounds ranging from 0.3 mM to 60 mM. The observed inhibi-
tion effect and IC50 values of these 12 compounds were confirmed by cell-
based in vivo assays.
2118-Plat
3D Culture of Human Muscle Cells Modulates Cell-Matrix Adhesions and
Actin Cytoskeleton Organization
Ste´phane Chiron1,2, Carole Tomczak1,2, Alain Duperray3, Jeanne Laine´1,2,
Gise`le Bonne1,2, Thomas Eschenhagen4, Claude Verdier5,6,
Catherine Coirault2,7.
1INSERM U974, Paris, France, 2UPMC, Paris, France, 3INSERM U823,
Grenoble, France, 4University Medical Center Hamburg-Eppendorf,
Hamburg, Germany, 5CNRS UMR5588, Grenoble, France, 6Universite´ de
Grenoble I, Grenoble, France, 7INSERM, Paris, France.
Anchorage of the muscular cells to the extracellular matrix is crucial for a range
of fundamental biological processes including migration, survival and differen-
tiation. However, muscle cell adhesions in a 3D environment and scaffold ri-
gidity of engineering muscle tissue (EMT) remain to be determined. We
aimed to characterize cell-matrix interactions in 3D muscle culture and to de-
termine their consequences on cell fate. Human myoblasts were embedded in
a fibrin matrix casted between 2 posts, cultured in 3D until confluence, then in-
duced to differentiate. Microscopic analysis revealed that the formation of ad-
hesion sites in 3D were smaller in size and number than in rigid 2D culture. The
expression of adhesion site proteins, including a5 and aV integrins, vinculin
and FAK, did not differ between 2D and 3D environments. Within the 3D myo-
blasts, the actin filaments typically formed cell projections and exhibited re-
duced actin stress fibers than their 2D counterparts. Concomitant to myotube
formation in 3D, actin filaments became densely packed and displayed parallel
aligned filaments oriented along the longest axis of the myotubes. Myoblasts
and myotubes in 3D exhibited thicker and ellipsoid nuclei instead of the thin
disk-like shape of the nuclei in 2D (p<0.001). Differentiation kinetics was
faster in 3D as attested by higher mRNA expressions of a-actinin and myosin
1 day after differentiation switch. Importantly, the elastic modulus of EMT in-
creased significantly from 3.550.8 kPa to 7.454.7 during proliferation and
reached 12.256.0 kPa during differentiation (each p<0.05), thus attesting to
increased stiffness during myocyte differentiation. In conclusion, we reported
modulations of adhesion, actin cytoskeleton and nucleus shape in 3D muscle
culture. Therefore, our results pointed out complex interactions between mus-
cle cells and the surrounding matrix with dynamic regulation of the cell-matrix
stiffness.
2119-Plat
Active Micropatterns, New Tool for Single Cell Studies
Martial Balland1, Kalpana Mandal2, Lionel Bureau3.
1UJF/CNRS Iiphy UMR558, Saint Martin d’He`res, France, 2UJF/CNRS
Fonfation nanosciences Iiphy UMR558, Saint Martin d’He`res, France,
3UJF/CNRS Iiphy UMR558, Saint Martin d’He`res, France.
Surface micropatterning is a powerful tool for the design of cell-based assays
(Quantitative Cell Phenotyping, Toxicology) and sensors, or for fundamental
studies of cellular response to environmental cues. The combination of surface
chemistry and microfabrication techniques allows to create substrates onto
which adhesion can be tuned so as to obtain regular 2D arrays of immobilized
cells. Such patterns have proven to be highly valuable for e.g. statistical anal-
ysis of the response of cells cultured in a well-controlled microenvironement
(drug delivery assays). Many different strategies have been developed to fab-
ricate surfaces presenting cell-adhesive patterns, among which the most pop-
ular are probably microcontact printing and photolithography. These
techniques have advantages and drawbacks in terms of ease of use, reproduc-
ibility, large scale homogeneity of the patterns and stability of the produced
surfaces. Here we present a new micropatterning technique dedicated to single
cell studies: this technique leads to a fast and robust fabrication of high-
resolution thermoresponsive micropatterns of which we think that the combi-
nation with microfluidic is a promising technology for drug or toxicology
assays.2120-Plat
Controlling Embryonic Cell Sheet Migration using Microfluidics
Melis Hazar1, YongTae Kim2, Jiho Song1, Philip R. Leduc3,
Lance A. Davidson4.
1Department of Mechanical Engineering, Carnegie Mellon University,
Pittsburgh, PA, USA, 2Koch Institute for Integrative Cancer Research
Massachsetts Institute of Technology, Boston, MA, USA, 3Departments of
Mechanical Engineering, Biomedical Engineering, and Biological Sciences,
Carnegie Mellon University, Pittsburgh, PA, USA, 4Departments of
Bioengineering and Developmental Biology, University of Pittsburgh,
Pittsburgh, PA, USA.
Embryonic development consists of a complex series of cell signaling, cell
migration and cell differentiation events whereas morphogenesis is the pro-
cess that controls the organized spatiotemporal distributions of these events.
Cell sheet migration is central to embryonic development, complex organs
system and diseases, therefore studying cell migration within sheets is impor-
tant. Embryos from the African Claw-toed frog, Xenopus laevis, are used to
elucidate genes important in moving cells. However, little is known about
the underlying mechanism by which cells in epithelial sheets coordinate their
responses to growth factors, directional signals, and motility cues to direct
sheet movement in vivo. One reason for this knowledge gap is the lack of
technologies to control of the chemical microenvironment surrounding multi-
cellular tissues. Here, we manipulate the chemical microenvironment with
precise spatiotemporal delivery of cytoskeletal inhibitors and contraction-
stimulating compounds using laminar flow interfaces with microfluidics. We
use this approach to study motility of the cells within the sheets to these lo-
calized environments and understand how their coordinated behavior works
with spatiotemporal control.
Microfluidics provides an opportunity to control chemical stimulation of bio-
logical systems using laminar flow interfaces with common flow modulation
methods. To deliver precise chemical stimulation to a multicellular tissue,
we have developed a system for controlling the inlet pressures to a microfluidic
device by modulating fluidic resistance and capacitance. We employed this sys-
tem to deliver chemicals over tissue explants fromXenopus embryos with a spa-
tiotemporal control to study mechanical patterning and local control of cell
sheet migration during epibolic-type morphogenetic movements.
We believe that patterning cell mechanics and controlling cell motility pro-
vide a means to initiate synthetic morphogenetic programs. In addition, the
ability to control the form of multicellular tissues potentially has high impact
in tissue engineering and regeneration applications in bioengineering and
medicine.Minisymposium: Ligand-gated Channels
2121-MiniSymp
A Prokaryotic Perspective on Pentameric Ligand-Gated Ion Channel
Structure and Function
Raimund Dutzler.
University of Zurich, Zurich, Switzerland.
The X-ray structures of two prokaryotic pentameric ligand-gated ion channels
(pLGICs) have provided first structural insight into the family at high resolu-
tion. The structure of GLIC, a proton-activated channel from the cyanobacte-
rium Gloebacter violaceous shows an open conformation of the pore. The
channel conducts cations with similar properties as the nicotinic acetylcholine
receptor and is inhibited by the same set of open channel blockers. The trans-
membrane pore is funnel-shaped with a wide hydrophobic entrance at the ex-
tracellular side that narrows to a hydrophilic intracellular opening. In this
region conserved residues coordinate ions which have lost a large part of their
hydration shell.
The structure of ELIC, a pLGIC from the plant pathogen Erwinia chrysanthemi
shows a non-conducting conformation of the channel that was obtained in the
absence of ligands. In its structure the extracellular half of the pore is occluded
by bulky hydrophobic residues that likely prevent ion conduction. ELIC is ac-
tivated by a set of primary amines that include the neurotransmitter GABA. The
protein forms cation selective channels with large single channel conductance
that slowly desensitize in the presence of ligands.
The strong structural similarity to their eukaryotic counterparts combined
with their comparably simpler functional behavior make ELIC and GLIC im-
portant model systems for the pLGIC family that will ultimately allow a de-
tailed comprehension of mechanistic properties that are still only poorly
understood.
